PF-05175157

N/A

Report date: 2022/07/04 19:38:02
NME

Base Information

Drug NamePF-05175157
Drug Alias NamePF-5175157PF-05175157
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionAcetyl-CoA carboxylase 2 inhibitorsAcetyl-CoA carboxylase 1 inhibitors
TargetsAcetyl-CoA carboxylase 1Acetyl-CoA carboxylase 2
Therapy Area/IndicationsDiabetes Mellitus, Type 2Diabetes MellitusGlucose Metabolism Disorders +[4] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusDiscontinued (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesPfizer Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesPfizer Inc
Active IndicationsN/A
Inactive IndicationsDiabetes Mellitus, Type 2Diabetes MellitusGlucose Metabolism Disorders +[4] 

Other Information

ATC CodeN/A
Related LinksN/A